Institutional Ownership Amylyx Pharmaceuticals, Inc. (AMLX)
This table provides information about the institutional ownership of Amylyx Pharmaceuticals, Inc. (AMLX). We have compiled data on the 149 institutions that hold shares in the stock, with a total of 72.6 Million shares, which have been reported (via 13F filing form) to have a value of $458 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Perceptive Advisors LLC
New York, NY |
May 15, 2025 Q1 2025 |
7,874,348
shares
|
$49.6 Million
1.17% of portfolio
|
Q1 2025
Added 16.24%
|
|
Tcg Crossover Management, LLC
Palo Alto, CA |
May 14, 2025 Q1 2025 |
5,943,812
shares
|
$37.4 Million
5.07% of portfolio
|
Q1 2025
Added 27.99%
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
May 15, 2025 Q1 2025 |
5,697,605
shares
|
$35.9 Million
0.04% of portfolio
|
Q1 2025
New holding
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
4,116,512
shares
|
$25.9 Million
0.0% of portfolio
|
Q1 2025
Added 52.89%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2025 Q1 2025 |
3,081,853
shares
|
$19.4 Million
0.01% of portfolio
|
Q1 2025
Added 418.62%
|
|
Nantahala Capital Management, LLC
New Canaan, CT |
May 15, 2025 Q1 2025 |
2,934,405
shares
|
$18.5 Million
0.47% of portfolio
|
Q1 2025
Added 102.07%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
2,757,776
shares
|
$17.4 Million
0.0% of portfolio
|
Q1 2025
Added 39.94%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,669,741
shares
|
$16.8 Million
0.0% of portfolio
|
Q2 2024
Reduced 40.34%
|
|
Abrdn PLC
|
May 13, 2025 Q1 2025 |
2,430,358
shares
|
$15.3 Million
0.02% of portfolio
|
Q1 2025
Added 41.07%
|
|
Saturn V Capital Management LLC
Austin, TX |
May 15, 2025 Q1 2025 |
2,426,436
shares
|
$15.3 Million
4.33% of portfolio
|
Q1 2025
Added 172.92%
|
|
683 Capital Management, LLC
New York, NY |
May 15, 2025 Q1 2025 |
2,411,400
shares
|
$15.2 Million
0.69% of portfolio
|
Q1 2025
Added 24.94%
|
|
Almitas Capital LLC
Santa Monica, CA |
May 15, 2025 Q1 2025 |
2,122,597
shares
|
$13.4 Million
4.25% of portfolio
|
Q1 2025
Added 4.44%
|
|
Goldman Sachs Group Inc
New York, NY |
Jun 26, 2025 Q1 2025 |
2,002,961
shares
|
$12.6 Million
0.0% of portfolio
|
Q1 2025
Added 7.69%
|
|
Great Point Partners LLC
Greenwich, CT |
May 15, 2025 Q1 2025 |
1,811,996
shares
|
$11.4 Million
3.97% of portfolio
|
Q1 2025
New holding
|
|
Woodline Partners LP
San Francisco, CA |
May 15, 2025 Q1 2025 |
1,609,447
shares
|
$10.1 Million
0.04% of portfolio
|
Q1 2025
New holding
|
|
Adar1 Capital Management, LLC
Austin, TX |
May 15, 2025 Q1 2025 |
1,471,587
shares
|
$9.27 Million
0.97% of portfolio
|
Q1 2025
New holding
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
May 14, 2025 Q1 2025 |
1,470,925
shares
|
$9.27 Million
0.0% of portfolio
|
Q1 2025
Added 69.39%
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
1,388,427
shares
|
$8.75 Million
0.0% of portfolio
|
Q1 2025
Added 115.75%
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
May 12, 2025 Q1 2025 |
1,199,691
shares
|
$7.56 Million
0.02% of portfolio
|
Q1 2025
Reduced 5.04%
|
|
Qube Research & Technologies LTD
London, X0 |
May 15, 2025 Q1 2025 |
942,891
shares
|
$5.94 Million
0.0% of portfolio
|
Q1 2025
Added 20.8%
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Jul 21, 2025 Q1 2025 |
916,966
shares
|
$5.78 Million
0.01% of portfolio
|
Q1 2025
New holding
|
|
Pfm Health Sciences, LP
San Francisco, CA |
May 15, 2025 Q1 2025 |
834,135
shares
|
$5.26 Million
0.24% of portfolio
|
Q1 2025
New holding
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
806,161
shares
|
$5.08 Million
0.0% of portfolio
|
Q1 2025
Added 41.95%
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2025 Q1 2025 |
794,354
shares
|
$5 Million
0.0% of portfolio
|
Q1 2025
Reduced 67.26%
|
|
Two Sigma Investments, LP
New York, NY |
May 15, 2025 Q1 2025 |
762,053
shares
|
$4.8 Million
0.01% of portfolio
|
Q1 2025
Added 16.97%
|